Tianjin Hankang Pharmaceutical Biotechnology | CAS 1187595-90-9 | Related Intermediates | Manufacturers & Suppliers

CAS 1187595-90-9

Chemistry, 1 End Use API, 14 Related Intermediates

Manufacturers/Suppliers

1 Suppliers

1 Suppliers

Also known as: 1187595-90-9, [4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate, 2,2-dimethyl-propionic acid 4-[1-(3-cyanomethyl-1-ethanesulfonyl-azetidin-3-yl)-1h-pyrazol-4-yl]-pyrrolo[2,3-d]pyrimidin-7-ylmethyl ester, Schembl870570, Amy9144, Bcp34619

Molecular Formula

C₂₂H₂₇N₇O₄S

Molecular Weight

485.6 g/mol

InChI Key

WENIISNHSRPUOW-UHFFFAOYSA-N

1 2D Structure

CAS 1187595-90-9

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate

2.1.2 InChI

InChI=1S/C22H27N7O4S/c1-5-34(31,32)28-12-22(13-28,7-8-23)29-11-16(10-26-29)18-17-6-9-27(19(17)25-14-24-18)15-33-20(30)21(2,3)4/h6,9-11,14H,5,7,12-13,15H2,1-4H3

2.1.3 InChI Key

WENIISNHSRPUOW-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CN(C4=NC=N3)COC(=O)C(C)(C)C

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1187595-90-9

2. [4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate

3. 2,2-dimethyl-propionic Acid 4-[1-(3-cyanomethyl-1-ethanesulfonyl-azetidin-3-yl)-1h-pyrazol-4-yl]-pyrrolo[2,3-d]pyrimidin-7-ylmethyl Ester

4. Schembl870570

5. Amy9144

6. Bcp34619

7. Cs-0456913

2.3 Create Date

2012-11-30

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₇N₇O₄S
Molecular Weight	485.6 g/mol
XLogP3	0.8
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	9
Exact Mass	485.18452354 g/mol
Monoisotopic Mass	485.18452354 g/mol
Topological Polar Surface Area	144 Å²
Heavy Atom Count	34
Formal Charge	0
Complexity	916
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Tianjin Hankang Pharmaceutical Biot...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

Ethyl 5-Chloropyrazolo[1,5-A]Pyrimidine-3-Carboxylate

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1224944-77-7

End Use API

Baricitinib

About the Company

Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enter...

Established in 1999, Hankang Pharmaceutical Group stands as a prominent CRO-CDMO integrated service enterprise in China. Focused on generic drugs while venturing into innovative ones, the group is dedicated to offering comprehensive solutions to the industry. Presently, Hankang has crafted over 200 varieties for 600+ domestic and international companies, serving 10+ innovative drugs. It has successfully developed more than 10 initial generic drugs, with over 20 varieties endorsed by the top three domestic companies and 30 exceeding a 100 million output value.

ASK
US